Back

Highly controllable co-delivery of siRNA and doxorubicin via cationic niosomes for synergistic anticancer effects

Song, P.; Liu, T.; Gothelf, K. V.; Kjems, J.

2025-09-09 bioengineering
10.1101/2025.09.04.674162 bioRxiv
Show abstract

The combination of anticancer drugs and siRNA has emerged as a promising strategy for cancer therapy due to their synergistic effects. However, a major challenge is developing a co-delivery system with high controllability capable of simultaneously encapsulating both the chemical drug and siRNA. In this study, we developed a simple and highly controllable co-delivery system for delivering Doxorubicin (Dox) and siRNA. Co-encapsulation was achieved by intercalating Dox into duplex GC-rich oligodeoxynucleotides, (CGA)7/(TCG)7 (termed CGA-Dox), followed by mixing with siRNA and subsequent condensation using a cationic noisome (SPN) through electrostatic interactions. SPN/siRNA/Dox exhibited efficient cellular uptake and high gene silencing efficiency in both H1299 and MDA-MB-231 cells. Furthermore, co-delivery of Dox and siRNA targeting ribonucleotide reductase subunit M2 (RRM2) using this system significantly enhanced cellular apoptosis and antiproliferative effect in MDA-MB-231 cells compared to Dox alone. These results indicate that our co-delivery system constructed via Dox-DNA intercalation and electrostatic complexation, represents a promising strategy for synergistic anticancer therapy.

Matching journals

The top 11 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.